Investigation of anti-motion sickness drugs in the squirrel monkey
about
AVP modulation of the vestibular nucleus via V1b receptors potentially contributes to the development of motion sickness in rat.Efficacy and safety of maropitant, a selective neurokinin 1 receptor antagonist, in two randomized clinical trials for prevention of vomiting due to motion sickness in dogs.A genetic polymorphism of the alpha2-adrenergic receptor increases autonomic responses to stress.Plasma vasopressin, an etiologic factor of motion sickness in rat and human?
P2860
Investigation of anti-motion sickness drugs in the squirrel monkey
description
1992 nî lūn-bûn
@nan
1992 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Investigation of anti-motion sickness drugs in the squirrel monkey
@ast
Investigation of anti-motion sickness drugs in the squirrel monkey
@en
Investigation of anti-motion sickness drugs in the squirrel monkey
@nl
type
label
Investigation of anti-motion sickness drugs in the squirrel monkey
@ast
Investigation of anti-motion sickness drugs in the squirrel monkey
@en
Investigation of anti-motion sickness drugs in the squirrel monkey
@nl
prefLabel
Investigation of anti-motion sickness drugs in the squirrel monkey
@ast
Investigation of anti-motion sickness drugs in the squirrel monkey
@en
Investigation of anti-motion sickness drugs in the squirrel monkey
@nl
P2093
P1476
Investigation of anti-motion sickness drugs in the squirrel monkey
@en
P2093
P2860
P304
P356
10.1002/J.1552-4604.1992.TB03822.X
P407
P577
1992-02-01T00:00:00Z